Back
Novo Nordisk A/S Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
44
NONOF
Novo Nordisk A/S
Last Price:
$59.82
Seasonality Move:
4.57%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atNovo Nordisk A/S Stock Forecast
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 24.6% based on the past 19 years of stock performance.
-
Novo Nordisk A/S has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
-
Is Novo Nordisk A/S Stock Undervalued?The current Novo Nordisk A/S [NONOF] share price is $55.01. The Score for NONOF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 24.6% based on the past 19 years of stock performance.
Novo Nordisk A/S Stock Rating
Sell
44
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S overpriced?
-
Novo Nordisk A/S has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
Novo Nordisk A/S Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
94.05
52-Week Low:
42.01
Prediction Charts
Market Cap:
244.4B
Price in USD:
55.01
Volume:
20.5K
Beta:
0.63
Technical Analysis
SMA50:
49.31
SMA100:
52.97
SMA200:
59.19
52-Wk Change:
-35.31%
Stock Predictions
-
Is Novo Nordisk A/S stock public?Yes, Novo Nordisk A/S is a publicly traded company.
-
What is the Novo Nordisk A/S stock quote today?The Novo Nordisk A/S stock price is 55.01 USD today.
-
How to buy Novo Nordisk A/S stock online?You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 46.66 | 47.67 | 48.72 | 46.22 |
| Dec-19 | 45.57 | 48.00 | 48.85 | 45.57 |
| Dec-22 | 47.29 | 47.97 | 48.63 | 46.60 |
| Dec-23 | 53.24 | 51.19 | 54.28 | 50.87 |
| Dec-24 | 54.43 | 52.11 | 54.43 | 51.00 |
| Dec-26 | 52.30 | 51.90 | 54.11 | 51.75 |
| Dec-29 | 53.12 | 51.50 | 53.12 | 51.00 |
| Dec-30 | 51.50 | 51.20 | 52.81 | 51.05 |
| Dec-31 | 48.63 | 51.05 | 52.00 | 48.63 |
| Jan-2 | 51.25 | 52.74 | 53.05 | 50.60 |
| Jan-5 | 53.50 | 55.77 | 56.39 | 53.24 |
| Jan-6 | 57.05 | 55.60 | 59.00 | 55.10 |
| Jan-7 | 58.64 | 57.32 | 58.64 | 56.32 |
| Jan-8 | 54.59 | 55.01 | 58.00 | 54.59 |
Novo Nordisk A/S Earnings
Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk A/S Forecast Revenue Growth
Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.